Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles

Article ID	Journal	Published Year	Pages	File Type
7861359	Journal of Controlled Release	2016	13 Pages	PDF

Keywords

PBS SEC-HPLC ribosomal protein large P0 l-PHA Peripheral artery disease (PAD)CD71 size exclusion high-performance liquid chromatography RPLP0 N-acetylgalactosamine GalNAc Hprt apoB s.c.i.v.i.p.ADC Transferrin GAPDH PNA Small interfering RNA S.D.siRNA β-actin Apolipoprotein B Peptide nucleic acid standard deviation intraperitoneal administration intramuscular injection Intravenous administration Subcutaneous administration Drug delivery system Skeletal muscle Actb FAL phosphate buffer saline Heart Conjugate Myostatin Targeting hypoxanthine-guanine phosphoribosyltransferase Antibody PAD Antibody drug conjugate glyceraldehyde 3-phosphate dehydrogenase

Related Topics

Physical Sciences and Engineering Materials Science Biomaterials

Preview

Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles

Authors

Tsukasa Sugo, Michiko Terada, Tatsuo Oikawa, Kenichi Miyata, Satoshi Nishimura, Eriya Kenjo, Mari Ogasawara-Shimizu, Yukimasa Makita, Sachiko Imaichi, Shumpei Murata, Kentaro Otake, Kuniko Kikuchi, Mika Teratani, Yasushi Masuda, Takayuki Kamei,